PDB Short entry for 1FM6 HEADER TRANSCRIPTION 16-AUG-00 1FM6 TITLE THE 2.1 ANGSTROM RESOLUTION CRYSTAL STRUCTURE OF THE HETERODIMER OF TITLE 2 THE HUMAN RXRALPHA AND PPARGAMMA LIGAND BINDING DOMAINS RESPECTIVELY TITLE 3 BOUND WITH 9-CIS RETINOIC ACID AND ROSIGLITAZONE AND CO-ACTIVATOR TITLE 4 PEPTIDES. COMPND MOL_ID: 1; COMPND 2 MOLECULE: RETINOIC ACID RECEPTOR RXR-ALPHA; COMPND 3 CHAIN: A, U; COMPND 4 FRAGMENT: LIGAND BINDING DOMAIN - RESIDUES 225 -462; COMPND 5 ENGINEERED: YES; COMPND 6 MOL_ID: 2; COMPND 7 MOLECULE: PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; COMPND 8 CHAIN: D, X; COMPND 9 FRAGMENT: LIGAND BINDING DOMAIN - RESIDUES 206 - 477; COMPND 10 ENGINEERED: YES; COMPND 11 MOL_ID: 3; COMPND 12 MOLECULE: STEROID RECEPTOR COACTIVATOR; COMPND 13 CHAIN: B, V, E, Y; COMPND 14 FRAGMENT: SRC-1 PEPTIDE; COMPND 15 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 6 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PACYC184; SOURCE 10 MOL_ID: 2; SOURCE 11 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 12 ORGANISM_COMMON: HUMAN; SOURCE 13 ORGANISM_TAXID: 9606; SOURCE 14 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 15 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 16 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 17 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 18 EXPRESSION_SYSTEM_PLASMID: PRSET; SOURCE 19 MOL_ID: 3; SOURCE 20 SYNTHETIC: YES; SOURCE 21 OTHER_DETAILS: CHEMICALLY SYNTHESIZED 25MER PORTION OF HUMAN SRC-1 SOURCE 22 COACTIVATOR PEPTIDE KEYWDS THE HETERODIMER OF THE NUCLEAR RECEPTOR LIGAND BINDING DOMAINS OF KEYWDS 2 RXRALPHA AND PPARGAMMA BOUND RESPECTIVELY WITH 9-CIS RETINOIC ACID KEYWDS 3 AND ROSIGLITAZONE AND CO-ACTIVATOR PEPTIDES, TRANSCRIPTION EXPDTA X-RAY DIFFRACTION AUTHOR R.T.GAMPE JR.,V.G.MONTANA,M.H.LAMBERT,A.B.MILLER,R.K.BLEDSOE, AUTHOR 2 M.V.MILBURN,S.A.KLIEWER,T.M.WILLSON,H.E.XU REVDAT 5 07-FEB-24 1FM6 1 REMARK REVDAT 4 04-OCT-17 1FM6 1 REMARK REVDAT 3 26-DEC-12 1FM6 1 HET HETNAM VERSN REVDAT 2 24-FEB-09 1FM6 1 VERSN REVDAT 1 16-FEB-01 1FM6 0 JRNL AUTH R.T.GAMPE JR.,V.G.MONTANA,M.H.LAMBERT,A.B.MILLER, JRNL AUTH 2 R.K.BLEDSOE,M.V.MILBURN,S.A.KLIEWER,T.M.WILLSON,H.E.XU JRNL TITL ASYMMETRY IN THE PPARGAMMA/RXRALPHA CRYSTAL STRUCTURE JRNL TITL 2 REVEALS THE MOLECULAR BASIS OF HETERODIMERIZATION AMONG JRNL TITL 3 NUCLEAR RECEPTORS. JRNL REF MOL.CELL V. 5 545 2000 JRNL REFN ISSN 1097-2765 JRNL PMID 10882139 JRNL DOI 10.1016/S1097-2765(00)80448-7 REMARK 2 REMARK 2 RESOLUTION. 2.10 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 0.5 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.10 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 20.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 2.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 372436.050 REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.0000 REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 87.8 REMARK 3 NUMBER OF REFLECTIONS : 59851 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.250 REMARK 3 FREE R VALUE : 0.292 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 10.100 REMARK 3 FREE R VALUE TEST SET COUNT : 6054 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.004 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.10 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.23 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 76.60 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 7798 REMARK 3 BIN R VALUE (WORKING SET) : 0.3860 REMARK 3 BIN FREE R VALUE : 0.3860 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 10.30 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 898 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.013 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 8292 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 94 REMARK 3 SOLVENT ATOMS : 452 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 24.70 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 55.50 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 28.20000 REMARK 3 B22 (A**2) : -14.96000 REMARK 3 B33 (A**2) : -13.24000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 6.25000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.34 REMARK 3 ESD FROM SIGMAA (A) : 0.50 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.39 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.48 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.011 REMARK 3 BOND ANGLES (DEGREES) : 1.500 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 21.10 REMARK 3 IMPROPER ANGLES (DEGREES) : 1.030 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.34 REMARK 3 BSOL : 53.72 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : BSXPI3.XPL REMARK 3 PARAMETER FILE 3 : WATER_REP.PARAM REMARK 3 PARAMETER FILE 4 : 9CRA_LOCAL3.XPL REMARK 3 PARAMETER FILE 5 : RSG_LOCAL3.XPL REMARK 3 PARAMETER FILE 6 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : NULL REMARK 3 TOPOLOGY FILE 3 : NULL REMARK 3 TOPOLOGY FILE 4 : NULL REMARK 3 TOPOLOGY FILE 5 : NULL REMARK 3 TOPOLOGY FILE 6 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1FM6 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 28-AUG-00. REMARK 100 THE DEPOSITION ID IS D_1000011706. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 01-JUN-99 REMARK 200 TEMPERATURE (KELVIN) : 93 REMARK 200 PH : 7.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 17-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MAR REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 64772 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.100 REMARK 200 RESOLUTION RANGE LOW (A) : 20.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 94.9 REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : 0.04900 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 25.7000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: NULL REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 47.86 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.36 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 17% PEG 4K, 200MM NASCN, 8% ETHYLENE REMARK 280 GLYCOL, PH 7.5, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 295K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 111.18200 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TETRAMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, D, B, E REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TETRAMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: U, X, V, Y REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 SER A 225 REMARK 465 ALA A 226 REMARK 465 HIS A 459 REMARK 465 GLN A 460 REMARK 465 MET A 461 REMARK 465 THR A 462 REMARK 465 SER U 225 REMARK 465 ALA U 226 REMARK 465 HIS U 459 REMARK 465 GLN U 460 REMARK 465 MET U 461 REMARK 465 THR U 462 REMARK 465 CYS B 619 REMARK 465 PRO B 620 REMARK 465 SER B 621 REMARK 465 SER B 622 REMARK 465 HIS B 623 REMARK 465 SER B 624 REMARK 465 SER B 625 REMARK 465 LEU B 626 REMARK 465 THR B 627 REMARK 465 GLU B 628 REMARK 465 ARG B 629 REMARK 465 GLY B 640 REMARK 465 SER B 641 REMARK 465 PRO B 642 REMARK 465 SER B 643 REMARK 465 CYS V 619 REMARK 465 PRO V 620 REMARK 465 SER V 621 REMARK 465 SER V 622 REMARK 465 HIS V 623 REMARK 465 SER V 624 REMARK 465 SER V 625 REMARK 465 LEU V 626 REMARK 465 THR V 627 REMARK 465 SER V 643 REMARK 465 CYS E 676 REMARK 465 PRO E 677 REMARK 465 SER E 678 REMARK 465 SER E 679 REMARK 465 HIS E 680 REMARK 465 SER E 681 REMARK 465 SER E 682 REMARK 465 LEU E 683 REMARK 465 THR E 684 REMARK 465 CYS Y 676 REMARK 465 PRO Y 677 REMARK 465 SER Y 678 REMARK 465 SER Y 679 REMARK 465 HIS Y 680 REMARK 465 SER Y 681 REMARK 465 SER Y 682 REMARK 465 LEU Y 683 REMARK 465 GLY Y 697 REMARK 465 SER Y 698 REMARK 465 PRO Y 699 REMARK 465 SER Y 700 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ASN A 227 CG OD1 ND2 REMARK 470 LYS A 245 CB CG CD CE NZ REMARK 470 THR A 246 CB OG1 CG2 REMARK 470 GLU A 247 CB CG CD OE1 OE2 REMARK 470 THR A 248 CB OG1 CG2 REMARK 470 TYR A 249 CB CG CD1 CD2 CE1 CE2 CZ REMARK 470 TYR A 249 OH REMARK 470 VAL A 250 CB CG1 CG2 REMARK 470 GLU A 251 CB CG CD OE1 OE2 REMARK 470 ALA A 252 CB REMARK 470 ASN A 253 CB CG OD1 ND2 REMARK 470 MET A 254 CB CG SD CE REMARK 470 LEU A 256 CB CG CD1 CD2 REMARK 470 ASN A 257 CB CG OD1 ND2 REMARK 470 PRO A 258 CB CG CD REMARK 470 SER A 259 CB OG REMARK 470 SER A 260 CB OG REMARK 470 PRO A 261 CB CG CD REMARK 470 ASN A 262 CB CG OD1 ND2 REMARK 470 ASP A 263 CB CG OD1 OD2 REMARK 470 PRO D 206 CG CD REMARK 470 ASN U 227 CG OD1 ND2 REMARK 470 LYS U 245 CB CG CD CE NZ REMARK 470 THR U 246 CB OG1 CG2 REMARK 470 GLU U 247 CB CG CD OE1 OE2 REMARK 470 THR U 248 CB OG1 CG2 REMARK 470 TYR U 249 CB CG CD1 CD2 CE1 CE2 CZ REMARK 470 TYR U 249 OH REMARK 470 VAL U 250 CB CG1 CG2 REMARK 470 GLU U 251 CB CG CD OE1 OE2 REMARK 470 ALA U 252 CB REMARK 470 ASN U 253 CB CG OD1 ND2 REMARK 470 MET U 254 CB CG SD CE REMARK 470 LEU U 256 CB CG CD1 CD2 REMARK 470 ASN U 257 CB CG OD1 ND2 REMARK 470 PRO U 258 CB CG CD REMARK 470 SER U 259 CB OG REMARK 470 SER U 260 CB OG REMARK 470 PRO U 261 CB CG CD REMARK 470 ASN U 262 CB CG OD1 ND2 REMARK 470 ASP U 263 CB CG OD1 OD2 REMARK 470 PRO X 206 CG CD REMARK 470 LYS X 261 CB CG CD CE NZ REMARK 470 ILE X 262 CB CG1 CG2 CD1 REMARK 470 LYS X 263 CB CG CD CE NZ REMARK 470 PHE X 264 CB CG CD1 CD2 CE1 CE2 CZ REMARK 470 LYS X 265 CB CG CD CE NZ REMARK 470 HIS X 266 CG ND1 CD2 CE1 NE2 REMARK 470 ARG X 357 CG CD NE CZ NH1 NH2 REMARK 470 LYS X 358 CG CD CE NZ REMARK 470 LYS B 631 CG CD CE NZ REMARK 470 LYS E 688 CG CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 OD1 ASP A 273 O THR A 449 2.16 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 PRO A 244 C - N - CA ANGL. DEV. = 20.1 DEGREES REMARK 500 PRO A 244 C - N - CD ANGL. DEV. = -22.6 DEGREES REMARK 500 PRO A 264 C - N - CA ANGL. DEV. = 9.5 DEGREES REMARK 500 PRO A 412 C - N - CA ANGL. DEV. = 9.6 DEGREES REMARK 500 PRO U 412 C - N - CA ANGL. DEV. = 9.1 DEGREES REMARK 500 PRO U 446 C - N - CA ANGL. DEV. = 10.3 DEGREES REMARK 500 HIS X 266 N - CA - C ANGL. DEV. = 18.3 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLU A 228 43.15 -108.41 REMARK 500 ASP A 229 -77.05 81.83 REMARK 500 MET A 230 73.30 -119.58 REMARK 500 ALA A 241 -4.45 -58.49 REMARK 500 VAL A 242 38.64 -147.18 REMARK 500 GLU A 243 -125.85 -57.25 REMARK 500 PRO A 244 -166.31 44.35 REMARK 500 LYS A 245 105.38 95.80 REMARK 500 THR A 246 175.50 45.91 REMARK 500 GLU A 247 -60.36 50.32 REMARK 500 VAL A 250 -34.26 -157.72 REMARK 500 ASN A 253 33.96 -179.24 REMARK 500 MET A 254 -29.61 169.54 REMARK 500 LEU A 256 -129.90 42.54 REMARK 500 ASN A 257 129.69 122.29 REMARK 500 PRO A 258 -168.30 -77.66 REMARK 500 SER A 259 -90.04 62.59 REMARK 500 SER A 260 41.89 91.23 REMARK 500 HIS A 288 -6.81 76.70 REMARK 500 LYS A 321 -80.11 -70.34 REMARK 500 ASP A 322 63.15 -113.67 REMARK 500 ARG A 334 -76.26 -37.73 REMARK 500 SER A 339 16.54 -63.22 REMARK 500 ALA A 344 -69.89 64.56 REMARK 500 LEU A 353 -68.11 -122.52 REMARK 500 LYS A 381 132.07 -39.73 REMARK 500 ILE A 442 -35.53 144.56 REMARK 500 ASP A 444 96.63 73.06 REMARK 500 PRO A 446 -157.76 -22.98 REMARK 500 THR A 449 -177.75 -64.15 REMARK 500 PHE A 450 -53.10 63.93 REMARK 500 LEU A 455 22.88 -70.25 REMARK 500 ALA A 457 150.81 56.55 REMARK 500 LYS D 240 160.03 -47.88 REMARK 500 THR D 241 106.41 65.40 REMARK 500 ASP D 243 -44.55 -178.95 REMARK 500 LYS D 244 124.47 -178.55 REMARK 500 GLU D 259 -70.31 -74.02 REMARK 500 ASP D 260 5.56 -58.98 REMARK 500 LYS D 265 178.66 -47.16 REMARK 500 THR D 268 -61.95 -99.95 REMARK 500 PRO D 269 -177.98 15.76 REMARK 500 LEU D 270 21.00 -159.92 REMARK 500 GLN D 271 28.47 173.44 REMARK 500 GLU D 272 103.62 -34.90 REMARK 500 GLN D 273 -141.63 8.98 REMARK 500 SER D 274 -23.71 75.19 REMARK 500 GLU D 276 141.18 -6.17 REMARK 500 SER D 342 73.34 44.77 REMARK 500 GLU D 343 24.17 49.63 REMARK 500 REMARK 500 THIS ENTRY HAS 113 RAMACHANDRAN OUTLIERS. REMARK 500 REMARK 500 REMARK: NULL REMARK 600 REMARK 600 HETEROGEN REMARK 600 REMARK 600 ROSIGLITAZONE IS A SYNTHETIC ANTIDIABETIC AGONIST FOR PPARGAMMA REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 9CR A 501 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 9CR U 502 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE BRL D 503 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE BRL X 504 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1FM9 RELATED DB: PDB REMARK 900 1FM9 CONTAINS THE SAME PROTEIN COMPLEXED WITH ANOTHER SYNTHETIC REMARK 900 ANTIDIABETIC AGONIST. DBREF 1FM6 A 225 462 UNP P19793 RXRA_HUMAN 225 462 DBREF 1FM6 U 225 462 UNP P19793 RXRA_HUMAN 225 462 DBREF 1FM6 D 206 477 UNP P37231 PPARG_HUMAN 204 475 DBREF 1FM6 X 206 477 UNP P37231 PPARG_HUMAN 204 475 DBREF 1FM6 B 619 643 UNP O43793 O43793 676 700 DBREF 1FM6 V 619 643 UNP O43793 O43793 676 700 DBREF 1FM6 E 676 700 UNP O43793 O43793 676 700 DBREF 1FM6 Y 676 700 UNP O43793 O43793 676 700 SEQRES 1 A 238 SER ALA ASN GLU ASP MET PRO VAL GLU ARG ILE LEU GLU SEQRES 2 A 238 ALA GLU LEU ALA VAL GLU PRO LYS THR GLU THR TYR VAL SEQRES 3 A 238 GLU ALA ASN MET GLY LEU ASN PRO SER SER PRO ASN ASP SEQRES 4 A 238 PRO VAL THR ASN ILE CYS GLN ALA ALA ASP LYS GLN LEU SEQRES 5 A 238 PHE THR LEU VAL GLU TRP ALA LYS ARG ILE PRO HIS PHE SEQRES 6 A 238 SER GLU LEU PRO LEU ASP ASP GLN VAL ILE LEU LEU ARG SEQRES 7 A 238 ALA GLY TRP ASN GLU LEU LEU ILE ALA SER PHE SER HIS SEQRES 8 A 238 ARG SER ILE ALA VAL LYS ASP GLY ILE LEU LEU ALA THR SEQRES 9 A 238 GLY LEU HIS VAL HIS ARG ASN SER ALA HIS SER ALA GLY SEQRES 10 A 238 VAL GLY ALA ILE PHE ASP ARG VAL LEU THR GLU LEU VAL SEQRES 11 A 238 SER LYS MET ARG ASP MET GLN MET ASP LYS THR GLU LEU SEQRES 12 A 238 GLY CYS LEU ARG ALA ILE VAL LEU PHE ASN PRO ASP SER SEQRES 13 A 238 LYS GLY LEU SER ASN PRO ALA GLU VAL GLU ALA LEU ARG SEQRES 14 A 238 GLU LYS VAL TYR ALA SER LEU GLU ALA TYR CYS LYS HIS SEQRES 15 A 238 LYS TYR PRO GLU GLN PRO GLY ARG PHE ALA LYS LEU LEU SEQRES 16 A 238 LEU ARG LEU PRO ALA LEU ARG SER ILE GLY LEU LYS CYS SEQRES 17 A 238 LEU GLU HIS LEU PHE PHE PHE LYS LEU ILE GLY ASP THR SEQRES 18 A 238 PRO ILE ASP THR PHE LEU MET GLU MET LEU GLU ALA PRO SEQRES 19 A 238 HIS GLN MET THR SEQRES 1 D 272 PRO GLU SER ALA ASP LEU ARG ALA LEU ALA LYS HIS LEU SEQRES 2 D 272 TYR ASP SER TYR ILE LYS SER PHE PRO LEU THR LYS ALA SEQRES 3 D 272 LYS ALA ARG ALA ILE LEU THR GLY LYS THR THR ASP LYS SEQRES 4 D 272 SER PRO PHE VAL ILE TYR ASP MET ASN SER LEU MET MET SEQRES 5 D 272 GLY GLU ASP LYS ILE LYS PHE LYS HIS ILE THR PRO LEU SEQRES 6 D 272 GLN GLU GLN SER LYS GLU VAL ALA ILE ARG ILE PHE GLN SEQRES 7 D 272 GLY CYS GLN PHE ARG SER VAL GLU ALA VAL GLN GLU ILE SEQRES 8 D 272 THR GLU TYR ALA LYS SER ILE PRO GLY PHE VAL ASN LEU SEQRES 9 D 272 ASP LEU ASN ASP GLN VAL THR LEU LEU LYS TYR GLY VAL SEQRES 10 D 272 HIS GLU ILE ILE TYR THR MET LEU ALA SER LEU MET ASN SEQRES 11 D 272 LYS ASP GLY VAL LEU ILE SER GLU GLY GLN GLY PHE MET SEQRES 12 D 272 THR ARG GLU PHE LEU LYS SER LEU ARG LYS PRO PHE GLY SEQRES 13 D 272 ASP PHE MET GLU PRO LYS PHE GLU PHE ALA VAL LYS PHE SEQRES 14 D 272 ASN ALA LEU GLU LEU ASP ASP SER ASP LEU ALA ILE PHE SEQRES 15 D 272 ILE ALA VAL ILE ILE LEU SER GLY ASP ARG PRO GLY LEU SEQRES 16 D 272 LEU ASN VAL LYS PRO ILE GLU ASP ILE GLN ASP ASN LEU SEQRES 17 D 272 LEU GLN ALA LEU GLU LEU GLN LEU LYS LEU ASN HIS PRO SEQRES 18 D 272 GLU SER SER GLN LEU PHE ALA LYS LEU LEU GLN LYS MET SEQRES 19 D 272 THR ASP LEU ARG GLN ILE VAL THR GLU HIS VAL GLN LEU SEQRES 20 D 272 LEU GLN VAL ILE LYS LYS THR GLU THR ASP MET SER LEU SEQRES 21 D 272 HIS PRO LEU LEU GLN GLU ILE TYR LYS ASP LEU TYR SEQRES 1 U 238 SER ALA ASN GLU ASP MET PRO VAL GLU ARG ILE LEU GLU SEQRES 2 U 238 ALA GLU LEU ALA VAL GLU PRO LYS THR GLU THR TYR VAL SEQRES 3 U 238 GLU ALA ASN MET GLY LEU ASN PRO SER SER PRO ASN ASP SEQRES 4 U 238 PRO VAL THR ASN ILE CYS GLN ALA ALA ASP LYS GLN LEU SEQRES 5 U 238 PHE THR LEU VAL GLU TRP ALA LYS ARG ILE PRO HIS PHE SEQRES 6 U 238 SER GLU LEU PRO LEU ASP ASP GLN VAL ILE LEU LEU ARG SEQRES 7 U 238 ALA GLY TRP ASN GLU LEU LEU ILE ALA SER PHE SER HIS SEQRES 8 U 238 ARG SER ILE ALA VAL LYS ASP GLY ILE LEU LEU ALA THR SEQRES 9 U 238 GLY LEU HIS VAL HIS ARG ASN SER ALA HIS SER ALA GLY SEQRES 10 U 238 VAL GLY ALA ILE PHE ASP ARG VAL LEU THR GLU LEU VAL SEQRES 11 U 238 SER LYS MET ARG ASP MET GLN MET ASP LYS THR GLU LEU SEQRES 12 U 238 GLY CYS LEU ARG ALA ILE VAL LEU PHE ASN PRO ASP SER SEQRES 13 U 238 LYS GLY LEU SER ASN PRO ALA GLU VAL GLU ALA LEU ARG SEQRES 14 U 238 GLU LYS VAL TYR ALA SER LEU GLU ALA TYR CYS LYS HIS SEQRES 15 U 238 LYS TYR PRO GLU GLN PRO GLY ARG PHE ALA LYS LEU LEU SEQRES 16 U 238 LEU ARG LEU PRO ALA LEU ARG SER ILE GLY LEU LYS CYS SEQRES 17 U 238 LEU GLU HIS LEU PHE PHE PHE LYS LEU ILE GLY ASP THR SEQRES 18 U 238 PRO ILE ASP THR PHE LEU MET GLU MET LEU GLU ALA PRO SEQRES 19 U 238 HIS GLN MET THR SEQRES 1 X 272 PRO GLU SER ALA ASP LEU ARG ALA LEU ALA LYS HIS LEU SEQRES 2 X 272 TYR ASP SER TYR ILE LYS SER PHE PRO LEU THR LYS ALA SEQRES 3 X 272 LYS ALA ARG ALA ILE LEU THR GLY LYS THR THR ASP LYS SEQRES 4 X 272 SER PRO PHE VAL ILE TYR ASP MET ASN SER LEU MET MET SEQRES 5 X 272 GLY GLU ASP LYS ILE LYS PHE LYS HIS ILE THR PRO LEU SEQRES 6 X 272 GLN GLU GLN SER LYS GLU VAL ALA ILE ARG ILE PHE GLN SEQRES 7 X 272 GLY CYS GLN PHE ARG SER VAL GLU ALA VAL GLN GLU ILE SEQRES 8 X 272 THR GLU TYR ALA LYS SER ILE PRO GLY PHE VAL ASN LEU SEQRES 9 X 272 ASP LEU ASN ASP GLN VAL THR LEU LEU LYS TYR GLY VAL SEQRES 10 X 272 HIS GLU ILE ILE TYR THR MET LEU ALA SER LEU MET ASN SEQRES 11 X 272 LYS ASP GLY VAL LEU ILE SER GLU GLY GLN GLY PHE MET SEQRES 12 X 272 THR ARG GLU PHE LEU LYS SER LEU ARG LYS PRO PHE GLY SEQRES 13 X 272 ASP PHE MET GLU PRO LYS PHE GLU PHE ALA VAL LYS PHE SEQRES 14 X 272 ASN ALA LEU GLU LEU ASP ASP SER ASP LEU ALA ILE PHE SEQRES 15 X 272 ILE ALA VAL ILE ILE LEU SER GLY ASP ARG PRO GLY LEU SEQRES 16 X 272 LEU ASN VAL LYS PRO ILE GLU ASP ILE GLN ASP ASN LEU SEQRES 17 X 272 LEU GLN ALA LEU GLU LEU GLN LEU LYS LEU ASN HIS PRO SEQRES 18 X 272 GLU SER SER GLN LEU PHE ALA LYS LEU LEU GLN LYS MET SEQRES 19 X 272 THR ASP LEU ARG GLN ILE VAL THR GLU HIS VAL GLN LEU SEQRES 20 X 272 LEU GLN VAL ILE LYS LYS THR GLU THR ASP MET SER LEU SEQRES 21 X 272 HIS PRO LEU LEU GLN GLU ILE TYR LYS ASP LEU TYR SEQRES 1 B 25 CYS PRO SER SER HIS SER SER LEU THR GLU ARG HIS LYS SEQRES 2 B 25 ILE LEU HIS ARG LEU LEU GLN GLU GLY SER PRO SER SEQRES 1 V 25 CYS PRO SER SER HIS SER SER LEU THR GLU ARG HIS LYS SEQRES 2 V 25 ILE LEU HIS ARG LEU LEU GLN GLU GLY SER PRO SER SEQRES 1 E 25 CYS PRO SER SER HIS SER SER LEU THR GLU ARG HIS LYS SEQRES 2 E 25 ILE LEU HIS ARG LEU LEU GLN GLU GLY SER PRO SER SEQRES 1 Y 25 CYS PRO SER SER HIS SER SER LEU THR GLU ARG HIS LYS SEQRES 2 Y 25 ILE LEU HIS ARG LEU LEU GLN GLU GLY SER PRO SER HET 9CR A 501 22 HET BRL D 503 25 HET 9CR U 502 22 HET BRL X 504 25 HETNAM 9CR (9CIS)-RETINOIC ACID HETNAM BRL 2,4-THIAZOLIDIINEDIONE, 5-[[4-[2-(METHYL-2- HETNAM 2 BRL PYRIDINYLAMINO)ETHOXY]PHENYL]METHYL]-(9CL) HETSYN BRL BRL49653; ROSIGLITAZONE FORMUL 9 9CR 2(C20 H28 O2) FORMUL 10 BRL 2(C18 H19 N3 O3 S) FORMUL 13 HOH *452(H2 O) HELIX 1 1 PRO A 231 ALA A 241 1 11 HELIX 2 2 VAL A 265 ILE A 286 1 22 HELIX 3 3 PRO A 293 SER A 317 1 25 HELIX 4 4 ARG A 334 SER A 339 1 6 HELIX 5 5 ALA A 344 LEU A 353 1 10 HELIX 6 6 LEU A 353 MET A 360 1 8 HELIX 7 7 ASP A 363 PHE A 376 1 14 HELIX 8 8 ASN A 385 TYR A 408 1 24 HELIX 9 9 GLY A 413 LEU A 420 1 8 HELIX 10 10 ARG A 421 LEU A 441 1 21 HELIX 11 11 PHE A 450 LEU A 455 1 6 HELIX 12 12 GLU D 207 PHE D 226 1 20 HELIX 13 13 THR D 229 GLY D 239 1 11 HELIX 14 14 ASP D 251 ASP D 260 1 10 HELIX 15 15 ASP D 260 LYS D 265 1 6 HELIX 16 16 GLU D 276 SER D 302 1 27 HELIX 17 17 ASP D 310 ALA D 331 1 22 HELIX 18 18 ARG D 350 LEU D 356 1 7 HELIX 19 19 PRO D 359 PHE D 363 5 5 HELIX 20 20 MET D 364 ALA D 376 1 13 HELIX 21 21 ASP D 380 LEU D 393 1 14 HELIX 22 22 ASN D 402 HIS D 425 1 24 HELIX 23 23 GLN D 430 GLU D 460 1 31 HELIX 24 24 HIS D 466 LYS D 474 1 9 HELIX 25 25 PRO U 231 VAL U 242 1 12 HELIX 26 26 THR U 246 VAL U 250 5 5 HELIX 27 27 VAL U 265 ILE U 286 1 22 HELIX 28 28 PRO U 293 SER U 317 1 25 HELIX 29 29 ILE U 318 VAL U 320 5 3 HELIX 30 30 HIS U 333 ALA U 340 1 8 HELIX 31 31 VAL U 342 LEU U 353 1 12 HELIX 32 32 LEU U 353 GLN U 361 1 9 HELIX 33 33 ASP U 363 PHE U 376 1 14 HELIX 34 34 ASN U 385 TYR U 408 1 24 HELIX 35 35 GLY U 413 LEU U 420 1 8 HELIX 36 36 ARG U 421 GLY U 443 1 23 HELIX 37 37 ASP U 448 MET U 454 1 7 HELIX 38 38 GLU X 207 PHE X 226 1 20 HELIX 39 39 THR X 229 GLY X 239 1 11 HELIX 40 40 ASP X 251 GLY X 258 1 8 HELIX 41 41 VAL X 277 LYS X 301 1 25 HELIX 42 42 GLY X 305 LEU X 309 5 5 HELIX 43 43 ASP X 310 ALA X 331 1 22 HELIX 44 44 ARG X 350 SER X 355 1 6 HELIX 45 45 MET X 364 ALA X 376 1 13 HELIX 46 46 ASP X 380 LEU X 393 1 14 HELIX 47 47 ASN X 402 HIS X 425 1 24 HELIX 48 48 GLN X 430 GLU X 460 1 31 HELIX 49 49 HIS X 466 LYS X 474 1 9 HELIX 50 50 HIS B 630 GLU B 639 1 10 HELIX 51 51 HIS V 630 GLU V 639 1 10 HELIX 52 52 HIS E 687 GLU E 696 1 10 HELIX 53 53 HIS Y 687 GLU Y 696 1 10 SHEET 1 A 2 GLY A 323 LEU A 325 0 SHEET 2 A 2 HIS A 331 HIS A 333 -1 O VAL A 332 N ILE A 324 SHEET 1 B 3 PHE D 247 ILE D 249 0 SHEET 2 B 3 GLY D 346 THR D 349 1 O PHE D 347 N ILE D 249 SHEET 3 B 3 GLY D 338 ILE D 341 -1 O VAL D 339 N MET D 348 SHEET 1 C 2 ILE U 324 LEU U 326 0 SHEET 2 C 2 LEU U 330 VAL U 332 -1 O LEU U 330 N LEU U 326 SHEET 1 D 4 PHE X 247 ILE X 249 0 SHEET 2 D 4 GLY X 346 THR X 349 1 O PHE X 347 N ILE X 249 SHEET 3 D 4 GLY X 338 ILE X 341 -1 N VAL X 339 O MET X 348 SHEET 4 D 4 MET X 334 ASN X 335 -1 N ASN X 335 O GLY X 338 CISPEP 1 GLU A 243 PRO A 244 0 1.05 CISPEP 2 GLU U 243 PRO U 244 0 -0.10 SITE 1 AC1 9 ALA A 271 GLN A 275 TRP A 305 PHE A 313 SITE 2 AC1 9 ARG A 316 LEU A 326 ALA A 327 CYS A 432 SITE 3 AC1 9 HIS A 435 SITE 1 AC2 7 ALA U 271 PHE U 313 ARG U 316 LEU U 326 SITE 2 AC2 7 ALA U 327 CYS U 432 HIS U 435 SITE 1 AC3 15 ILE D 281 PHE D 282 GLY D 284 CYS D 285 SITE 2 AC3 15 SER D 289 HIS D 323 LEU D 330 ILE D 341 SITE 3 AC3 15 MET D 348 MET D 364 HIS D 449 LEU D 453 SITE 4 AC3 15 LEU D 469 TYR D 473 HOH D 583 SITE 1 AC4 10 PHE X 282 GLY X 284 CYS X 285 SER X 289 SITE 2 AC4 10 HIS X 323 TYR X 327 MET X 364 HIS X 449 SITE 3 AC4 10 LEU X 453 TYR X 473 CRYST1 49.255 222.364 55.289 90.00 98.59 90.00 P 1 21 1 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.020303 0.000000 0.003069 0.00000 SCALE2 0.000000 0.004497 0.000000 0.00000 SCALE3 0.000000 0.000000 0.018292 0.00000